1. Article | 2017.09.12

    Pasteur-Paris University enrollment 2018

    The 2017-2018 call for enrollment of students in October 2018 is open.

  2. News | 2020.05.14

    LuLISA project, bioluminescence as a tool for human diagnostics, from allergy to Covid19

    The LuLISA (Luciferase-Linked ImmunoSorbent Assay) research project aims developing high throughput serological tests for epidemiological studies at local, regional or nation scales. In a recent scientific publication, concerning the detection and dosing of IgE specific to several allergens in patients’ blood samples, the use of LuLISA proves to be a vastly improved detection method in...

  3. Article | 2021.08.03

    Neurodegenerative Diseases​

    Department of Cell Biology & InfectionSandrine Etienne-Manneville - Astrocytic responses to inflammatory situationsAstrocytes form the majority of glial cells of the central nervous system. They play a key role in brain homeostasis, they serve as physical and nutritional support for neurons and they directly participate in synaptic transmission. In inflammatory situations, such as...

  4. Article | 2017.01.03

    Pasteur-Paris University International doctoral program​ (PPU)

    The Institut Pasteur organizes a doctoral program in collaboration with Université Paris Cité, Sorbonne Université, and Université Paris Saclay, for students holding a master degree or the equivalent in science, medicine and related fields.

  5. Document de presse | 2015.10.28

    The Institut Pasteur and Chan Soon-Shiong Institute for Molecular Medicine Partner to Form Global Genomics Center

    Paris, France and Los Angeles, CaliforniaThe Chan Soon-Shiong Institute for Molecular Medicine (CSSIOMM) and the Institut Pasteur today announced a partnership to establish The Pasteur Global Health Genomics Center (PGHGC). The aim of the PGHGC is to advance genomic research utilizing next-generation patient information systems needed to support the acquisition and usage of high-quality...

  6. Article | 2020.03.27

    Coronavirus (Covid-19) research projects

    VACCINE CANDIDATES1. Development of an animal model and accelerated development of a DNA vaccine candidate(SCARD SARS-CoV-2 project)Aims:To develop a mouse model of SARS-CoV-2 infection.This will not only enable us to evaluate the efficacy of the vaccine; it will also facilitate in vivo research on SARS-CoV-2. To evaluate the immunogenicity (ability to induce a specific immune reaction) and...

  7. Article | 2021.08.03

    Neuro-inflammation and Neuro-infection

    Department of Cell Biology & InfectionSandrine Etienne-Manneville - Astrocytic responses to inflammatory situationsAstrocytes form the majority of glial cells of the central nervous system. They play a key role in brain homeostasis, they serve as physical and nutritional support for neurons and directly participate in synaptic transmission. In inflammatory situations, such as those...

  8. Document de presse | 2014.09.09

    Highly regulated therapeutic target shows promise in the search for new antimalarial treatments

    Artemisinin is currently the most effective malarial treatment available. However, the recent emergence in South-East Asia of artemisinin-resistant parasites strengthens the urgent need to identify a new generation of antimalarial drugs. In this context, scientists at the Institut Pasteur and CNRS have determined the three-dimensional structure of a promising new therapeutic target for malaria:...

  9. Document de presse | 2013.02.06

    Treatment of Cutaneous Leishmaniasis: Study of Phase III Shows Antibiotic Cream Has High Cure Rate, Few Side Effects

    An international research partnership from Tunisia, France and the United States has demonstrated a high cure rate and remarkably few side effects in treating patients with cutaneous leishmaniasis (CL) with an antibiotic cream. CL is a parasitic disease that causes disfiguring lesions and affects 1.5 million people worldwide annually, including the socio-economically disadvantaged in the...

  10. Document de presse | 2016.11.08

    The ADITEC Project on Advanced Immunization Technologies: an European Success Story

    30 million Euros of funding, 42 public and private institutions have joined forces for next generation vaccines.The ADITEC project was presented today at the European Parliament as a Success Story.Development of novel immunisation technologies, adjuvants, vectors and delivery systems, formulations and vaccination methods optimised for different age groups, 207 scientific publications,  and...

Pages

Back to top